NCT02188745: A trial that was reported late by Dartmouth-Hitchcock Medical Center
This trial has reported, although it was 102 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT02188745 |
|---|---|
| Title | Phase II Pre-emptive OsciLLation of ER activitY Levels Through Alternation of Estradiol/Anti-estrogen Therapies Prior to Disease Progression in ER+/HER2- Metastatic or Advanced Breast Cancer |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | March 11, 2016 |
| Completion date | Jan. 5, 2024 |
| Required reporting date | Jan. 5, 2025, midnight |
| Actual reporting date | April 17, 2025 |
| Date last checked at ClinicalTrials.gov | May 16, 2025 |
| Days late | 102 |